Cargando…
A Cell-Penetrating Peptide That Blocks Toll-Like Receptor Signaling Protects Kidneys against Ischemia-Reperfusion Injury
Renal ischemia-reperfusion injury (IRI) is involved in the majority of clinical conditions that manifest as renal function deterioration; however, specific treatment for this type of injury is still far from clinical use. Since Toll-like receptor (TLR)-mediated signaling is a key mediator of IRI, we...
Autores principales: | Jung, Su Woong, Seo, Jung-Woo, Park, Seon Hwa, Kim, Yang Gyun, Moon, Ju-Young, Choi, Sangdun, Lee, Sang-Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7915942/ https://www.ncbi.nlm.nih.gov/pubmed/33562802 http://dx.doi.org/10.3390/ijms22041627 |
Ejemplares similares
-
A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice
por: Kwon, Hyuk-Kwon, et al.
Publicado: (2019) -
Substance P Improves Renal Ischemia Reperfusion Injury Through Modulating Immune Response
por: Kim, Dong-Jin, et al.
Publicado: (2020) -
A cell‐penetrating CD40‐TRAF2,3 blocking peptide diminishes inflammation and neuronal loss after ischemia/reperfusion
por: Portillo, Jose‐Andres C., et al.
Publicado: (2021) -
Toll-Like Receptors in Hepatic Ischemia/Reperfusion and Transplantation
por: Evankovich, John, et al.
Publicado: (2010) -
Toll-Like Receptors and Myocardial Ischemia/Reperfusion, Inflammation, and Injury
por: Kaczorowski, David J, et al.
Publicado: (2009)